InvestorRelations
Please contact us for any investor information using the form below.
CurrentNews
EmpowerPharm Inc. Announces First Patient Dosed in a Phase II Study Evaluating Empower CBD™ for the Treatment of Social Anxiety Disorder
EmpowerPharm Inc a clinical-stage life sciences company focused on research and clinical development announced today that the first patient has been dosed in their Company-sponsored Phase II clinical study.
EmpowerPharm Inc. Announces First Patient Enrolled in a Phase II Study Evaluating Empower CBD™ for the Treatment of Social Anxiety Disorder
EmpowerPharm Inc a clinical-stage life sciences company focused on research and clinical development announced today that the first patient has been enrolled in their Company-sponsored Phase II clinical study.
EmpowerPharm Inc. welcomes Terri-Jean (TJ) Geddis
TJ is a commercial leader with over 25 years of experience in both the pharmaceutical and biotech industries. She started her career at larger companies such as Eli Lilly and with her entrepreneurial mindset, gravitated to smaller, Canadian start-up organizations such as Alexion and Mitsubishi Tanabe Pharma.